Last Seven Days

29 articles from the last seven days

• 
  Qld radiopharma defends manufacturing process

  AdvanCell has challenged two patent application by a Norwegian company that cover the production of the radioisotope used in its flagship product

  3 Nov 2026
• 
  AZ shuffles jobs to prep huge pipeline

  The UK pharma giant has announced a "reshaping" programme which will see jobs lost in some areas but gained in others

  3 Nov 2026
• 
  Aussie study applauds new-gen Novartis drug

  South Australian researchers have described one of Novartis' fastest-growing brands as "a huge step forward" in frontline treatment options

  3 Nov 2026
• 
  Aussies continue FDA winning streak

  Melbourne-based pharma notches another win in the US with the granting of an Orphan Drug designation, marking an important commercial milestone

  2 Nov 2026
• 
  Federal Court slaps company with $6.5M fine

  TGA wins its case against a company which unlawfully advertised prescription-only medicines, which the judge described as a "deliberate commercial strategy"

  2 Nov 2026
• 
  Ex-Novartis GM snapped up for global role

  So that's where he's gone... Well-known Aussie pharma exec has been tapped for a global position, joining a new company at a time of significant growth

  2 Nov 2026
• 
  Who nabbed half the November PBS listings?

  Eight drugs won reimbursement over the weekend, with half of the medicines belonging to one pharma

  2 Nov 2026
• 
  Three pharmas hit with first rival

  The TGA has approved the first copycats of long-standing drugs sponsored by Bayer, Link Medical Products, and Novo in Australia

  2 Nov 2026
• 
  AbbVie pitches a world-class PBS

  As concerns grow over Australia’s lagging access to medicines, AbbVie has released a report exposing just how far the country has fallen behind and who is paying the price

  2 Nov 2026